Trial Profile
Evaluation of a Biobehavioral Intervention for Hot Flashes.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Hot flashes
- Focus Therapeutic Use
- 15 Dec 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2015.
- 15 Dec 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Nov 2012.
- 15 Dec 2016 Planned initiation date changed from 1 Oct 2009 to 1 Nov 2009.